Baylis Medical Company
10
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
20.0%
2 terminated/withdrawn out of 10 trials
75.0%
-11.5% vs industry average
10%
1 trials in Phase 3/4
67%
4 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Feasibility And Safety Of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Using A Radiofrequency Guidewire
Role: collaborator
Wire Instrumentation Using Radiofrequency Energy to Impact Transseptal Efficiency
Role: collaborator
Early Aggressive Invasive Intervention for Atrial Fibrillation
Role: collaborator
Conventional Versus RF Needle Transseptal Puncture for Cryoballoon Ablation
Role: collaborator
Non-fluoroscopy Ablation of AF/AT
Role: collaborator
Transseptal Needle Versus Radiofrequency Energy for Left Atrial Access
Role: collaborator
Placebo-controlled Trial of Transdiscal Radiofrequency Annuloplasty
Role: lead
Trial Assessing Cooled Radiofrequency Denervation as a Treatment for Sacroiliac Joint Pain Using the Sinergy System
Role: lead
Trial Comparing Treatment With SInergy™ System to Conservative Treatment for Chronic Sacroiliac Joint Pain
Role: lead
Trial of Disc Biacuplasty to Treat Chronic Discogenic Low Back Pain
Role: lead
All 10 trials loaded